Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07530081) titled 'The Impact of Oral Probiotics on Improving the Quality of Life in Patients With Dysmenorrhea' on April 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
Primary Sponsor: Glac Biotech Co., Ltd
Condition:
Dysmenorrhea
Intervention:
Dietary Supplement: High dose Probiotic
Dietary Supplement: Low dose probiotic
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 4, 2024
Target Sample Size: 150
Countries of Recruitment:
Taiwan
To know more, visit htt...